cost-effectiveness analysis of apixaban compared to low-molecularweight heparins and vitamin k antagonists for treatment.成本效益分析的apixaban相比low-molecular
本文档由 ccyyjie 分享于2017-01-11 23:49
cost-effectiveness analysis of apixaban compared to low-molecularweight heparins and vitamin k antagonists for treatment.成本效益分析的apixaban相比low-molecular
下载文档
收藏
打印
君,已阅读到文档的结尾了呢~~